Total Voting Rights

AI SummaryClose X

Solvonis Therapeutics plc announced that its issued share capital as of October 31, 2025, comprises 6,806,403,493 ordinary shares, each with one voting right. The company holds no ordinary shares in treasury, resulting in a total of 6,806,403,493 ordinary shares and voting rights. This includes a correction to a previously announced share issue on the same date, with the accurate figure for shares issued and admitted being 23,636,362, revised down from the originally stated 26,636,362 shares. This figure is relevant for shareholders determining their notification requirements regarding their interest in the company's share capital.

Disclaimer*

UK 100

Latest directors dealings